Lilly launches end-to-end digital healthcare experience through LillyDirect
Eli Lilly and Company announced LillyDirect, a new digital healthcare experience for patients in the US living with obesity, migraine and diabetes. LillyDirect offers disease management resources, including access to independent healthcare providers, tailored support, and direct home delivery of select Lilly medicines through third-party pharmacy dispensing services.
"A complex US healthcare system adds to the burdens patients face when managing a chronic disease. With LillyDirect, our goal is to relieve some of those burdens by simplifying the patient experience to help improve outcomes," said David A Ricks, Lilly's Chair and CEO. "LillyDirect offers more choices in how and where people access healthcare, including a convenient home delivery option to fill Lilly medicines they have been prescribed."
For patients living with obesity, migraine and diabetes, LillyDirect offers:
- LillyDirect Pharmacy Solutions, a digital pharmacy for select Lilly medicines powered by third-party online pharmacy fulfillment services. LillyDirect Pharmacy Solutions gives patients a simple option to get consistent access to Lilly medicines they have been prescribed with the added convenience of home delivery. By obtaining medicines directly from Lilly, patients can easily access Lilly's affordability solutions and savings card opportunities are automatically applied for patients who qualify. Medicines fulfilled by pharmacy service providers through LillyDirect Pharmacy Solutions ship free of charge.
- Disease state and healthcare educational information to help empower and support patients on their care journeys.
- Access to independent telehealth providers that could complement a patient's current primary care team or be an alternative to in-person care for certain conditions.
- An independent search tool that allows a patient to find healthcare professionals near them if they prefer in-person care.
Recommended
Dozee Shravan to remotely monitor patients
October 8, 2024
WHO adds an HPV vaccine for single-dose use
October 8, 2024